Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status PDPA Q4 2025 Earnings EPS Slightly Below Estimates Preferred Stock Unchanged OI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Slips BGSI Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Edges Lower NEWTI Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed